Baseline characteristics of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER): Successful enrollment of a diverse clinical trial cohort at risk for cognitive decline.
Whitmer RA, Baker LD, Carrillo MC, Snyder HM, Cleveland ML, Gitelman DR, Kivipelto M, Leng XI, Lovato L, Papp KV, Pavlik VN, Salloway SP, Tangney CC, Farias ST, Williamson JD, Wilmoth S, Woolard N, Yu M, Espeland MA; U.S. POINTER Study Group.
Whitmer RA, et al. Among authors: leng xi.
Alzheimers Dement. 2025 Jun;21(6):e70351. doi: 10.1002/alz.70351.
Alzheimers Dement. 2025.
PMID: 40556311
Free PMC article.
Clinical Trial.